Lumbokinase capsules, CAS 556743-18-1

Product Description: Lumbokinase capsules attenuates myocardial ischemia-reperfusion (I-R) injury through the activation of Sirt1 signaling, and thus enhances autophagic flux and reduces I-R-induced oxidative damage, inflammation and apoptosis[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Wang YH, et, al. Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury. Front Pharmacol. 2018 Jun 15;9:636.

CAS Number: 556743-18-1

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Sirtuin

• Artikelnummer: MEXHY-E70008-5G
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-E70008-5G
• Verpackungseinheit: 5g
• Mengeneinheit: STK